Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-001262 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
26,668
Total Value
$52,689.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 5, 2026 | Sale | 4,000 | $1.96 | $7,838.00 | 157,127 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 6, 2026 | Sale | 7,097 | $1.97 | $13,961.22 | 150,030 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 6, 2026 | Sale | 3,801 | $1.97 | $7,476.57 | 146,229 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 7, 2026 | Sale | 1,700 | $1.99 | $3,378.92 | 144,529 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 7, 2026 | Sale | 10,070 | $1.99 | $20,035.27 | 134,459 | Direct | โ | View Details |